Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...

Learn how radiopharmaceuticals are transforming nuclear medicine and cancer therapy through targeted diagnostics and ...

Health Cabinet Secretary Aden Duale has instructed national referral hospitals, the Social Health Authority (SHA), and the ...

The ERVI is reviewing the EU's production capacity for metallic HALEU. It is also looking at ways to enhance the production ...

As previously announced, the FDA also granted iopofosine I 131 Fast Track Designation and Orphan Drug Designation. The ...

Song, Z. and Zhong, W. (2025) Research Advances in Subtype Classification and Diagnosis of Primary Aldosteronism. Journal of Biosciences and Medicines, 13, 1-11. doi: 10.4236/jbm.2025.136001 .

Missouri Gov. Mike Kehoe is now asking lawmakers to give the University of Missouri $50 million for cancer research.

The radioisotopes are bound to biological molecules ... The drive to bolster the pipeline of oncology assets has seen a range of new treatment modalities be adopted in the therapeutic area.

The emergence of alpha-emitting radioisotopes, such as Actinium-225 ... including radiation oncologists and treatment centres capable of administering radiopharmaceuticals, is necessary.

Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive mHSPC: Basel Tuesday, June 3, 2025, 12:00 Hrs [IST] ...

The Israeli attack in 1981, known as "Operation Opera," destroyed the site and killed at least 11 Iraqis, including military ...

The Varian Ethos 2.0 technology is part of UH's broader cancer care initiative, which includes a new $39 million regional ...